Results 31 to 40 of about 359,892 (267)

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

open access: yesMolecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano   +6 more
wiley   +1 more source

Five Years of EU Roma Integration Policies: Vanishing Gender Awareness? IES Policy Brief Issue 2016/14• May 2016 [PDF]

open access: yes, 2016
The EU Framework for National Roma Integration Strategies up to 2020 has recently turned five. As for any anniversary worthy of the name, a general assessment of both the first results and the necessary steps forward needs to be made.
D’Agostino, Serena
core  

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

The ‘Roma Question’ in Slovakia

open access: yesActa Universitatis Sapientiae: European and Regional Studies, 2018
Slovakia belongs to those states with a high number of Romani in terms of population – of the population of about 5.3 million, 480 to 520 thousand people have Romani origin. In Slovakia, only since 1999 have the Gypsies been able to call themselves Roma.
Macsó Kinga
doaj   +1 more source

When Decarbonisation meets Disinformation: EU-Russia Energy Relations. IES Policy Brief Issue 2016/15•June 2016 [PDF]

open access: yes, 2016
The EU Framework for National Roma Integration Strategies up to 2020 has recently turned five. As for any anniversary worthy of the name, a general assessment of both the first results and the necessary steps forward needs to be made.
D'Agostino, Serena
core  

Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize whole‐body intramuscular fat distribution pattern in patients with sarcoglycanopathies and explore correlations with disease severity, duration and age at onset. Methods Retrospective, cross‐sectional, multicentric study enrolling patients with variants in one of the four sarcoglycan genes who underwent whole‐body ...
Laura Costa‐Comellas   +39 more
wiley   +1 more source

SPG4 and Dementia: Expanding the Clinical Spectrum

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza   +19 more
wiley   +1 more source

Civil Society Monitoring Report on the Implementation of the National Roma Integration Strategy and Decade Action Plan in 2012 in: the Czech Republic [PDF]

open access: yes, 2013
The situation of the Roma minority is one of the Czech Republic's most urgent social and human rights problems. The Czech Republic seeks to address this complex problem with a wide range of activities.
Jakob Hurrle   +7 more
core  

The 5th edition of the Roma-BZCAT. A short presentation [PDF]

open access: yes, 2015
The 5th edition of the Roma-BZCAT Multifrequency Catalogue of Blazars is available in a printed version and online at the ASDC website (http://www.asdc.asi.it/bzcat); it is also in the NED database.
Giommi, Paolo   +6 more
core   +2 more sources

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy